Industry
Merck, BMS Give Ground On ARVs
March 2006 | Company Finance AlertUS drug firms Merck & Co and Bristol-Myers Squibb (BMS) have announced significant concessions on their ARVs in recent months. The moves come as calls grow for greater public access to the medicines in the developing
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
